Published online by Stanford Medicine News Centre, this article reports on a small early stage clinical trial at Stanford University. The trial was conducted to evaluate the safety of giving patients with mild to moderate Alzheimers, infusions of blood plasma from young producers. Unexpectedly in the trial benefits in tests of functional performance by those patients were reported, primarily by their carers. The trial wasn’t designed to test these parameters and obviously further testing needs to be undertaken. Still very, very interesting. Also interesting is that the article reports that the intellectual property for the regime of infusing patients with plasma from 18-30 year old producers is owned by a private biotechnology company called Alkahest.
Detail of a work in current progress in the series on the story ‘twenty three units of blood’. All of those units of blood were donated in the sense that they were given without monetary reward. In Australia when you donate blood you receive thanks, a cup of tea, a biscuit and if you are really good, a lolly.
I posted in August 2017 about the blood and blood products production business including a link to a documentary shown on the Australian, ABC, Four Corners programme. http://iview.abc.net.au/programs/four-corners/NC1704H029S00. Not sure if it is still online but here is the link for you to copy and paste if you’re interested. It raises ethical questions about what could be described as the farming of humans for profit or as additional ways for individuals to earn money by selling their plasma on a regular basis.
One thought on “Infusions of plasma from young producers shown to be of benefit in a small trial of patients with mild to moderate Alzheimers.”
Fascinating… especially after reading the weekend SMH article about the rise and rise of CSL on the back of the volunteer blood/plasma donor. Lolly schmolly.